C3 and ovarian carcinoma: Complement activation has recently been shown to occur in ovarian cancer cells due to an autocrine effect that produces complement C3 protein, which leads to alterations in the tumor microenvironment by increasing the number of myeloid-derived suppressor cells and reducing the number of cytotoxic T cells that infiltrate into the tumor, which promotes tumor growth26.